These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 951688)

  • 1. [Eraldin-induced pleurisy].
    Reinholdtsen J
    Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1130. PubMed ID: 951688
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: practolol-induced pleurisy and constrictive pericarditis.
    Dyer NH; Varley CC
    Br Med J; 1975 May; 2(5968):443. PubMed ID: 1125574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practolol (Eraldin)-induced peritoneal fibrosis?].
    Fredhall S
    Tidsskr Nor Laegeforen; 1976 Jan; 96(3):154-5. PubMed ID: 1251369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sclerosing peritonitis following the use of practolol (Eraldin)].
    Braam JI; Reisma K; Luiken HC; van Hees CA; Oeberius Kapteyn JL; Henneveld HE; Van Beugen L; Hensen A
    Ned Tijdschr Geneeskd; 1975 Jun; 119(25):1000-5. PubMed ID: 1143582
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complications in treatment with beta blockader Practolol (Eraldin)].
    Brinck HP; Aasved H; Jacobsen KB
    Tidsskr Nor Laegeforen; 1975 Aug; 95(24):1357-9, 1352. PubMed ID: 126503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Skin and ocular lesions following long-term treatment with practolol (Eraldin)].
    Mikkelsen HI; Jensen HA; Wadskov S; Sondergaard J
    Ugeskr Laeger; 1975 Sep; 137(38):2188-91. PubMed ID: 1166556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Practolol (Eraldin and sclerosing peritonitis].
    Moller JC; Nielsen SB
    Ugeskr Laeger; 1975 Sep; 137(38):2192-4. PubMed ID: 1166557
    [No Abstract]   [Full Text] [Related]  

  • 8. Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
    Wright P
    Br Med J; 1975 Mar; 1(5958):595-8. PubMed ID: 1125623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Hearing disorders following use of practolol (Eraldin)].
    van Gelder L
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1285. PubMed ID: 1165799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psoriatic skin changes during practolol (Eraldin) treatment].
    Mikkelsen HI
    Ugeskr Laeger; 1974 Oct; 136(42):2358-60. PubMed ID: 4423785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sclerosing peritonitis and practolol (Eraldin)].
    Algaard A; Knudsen O; Solheim KE
    Tidsskr Nor Laegeforen; 1976 Apr; 96(12):696-7. PubMed ID: 936122
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular disorders resulting from treatment with practolol (Eraldin) [proceedings].
    Cruysberg JR; Pinckers A
    Ophthalmologica; 1977; 175(1):39-40. PubMed ID: 904900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conjunctivitis, stomatitis, glossitis, otitis and psoriasiform skin diseases during long-term treatment with practolol (Eraldin)].
    Byrn E; Reersted P
    Ugeskr Laeger; 1975 Apr; 137(18):1019-20. PubMed ID: 124970
    [No Abstract]   [Full Text] [Related]  

  • 14. [Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].
    Ugeskr Laeger; 1975 Apr; 137(18):1016-7. PubMed ID: 124969
    [No Abstract]   [Full Text] [Related]  

  • 15. Eosinophilic pleurisy induced by dantrolene.
    Urano T; Nishiumi M; Tajiri S; Ishii H; Tanigaki T; Kobayashi K; Kita F; Tokuoka K; Nagayama M; Eguchi K
    Tokai J Exp Clin Med; 2005 Sep; 30(3):189-92. PubMed ID: 16285611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practolol peritonitis with autopsy findings.
    Hayton AC
    N Z Med J; 1978 Mar; 87(607):177-9. PubMed ID: 274658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practolol and deafness.
    Jones RF; Hammond VT; Wright D; Ballantyne JC
    J Laryngol Otol; 1977 Nov; 91(11):963-72. PubMed ID: 145453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy].
    Lunde I; Borchgrevink CF
    Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1609. PubMed ID: 1179394
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of armored heart diagnosed after death].
    Krauze J
    Wiad Lek; 1970 Jun; 23(11):929-31. PubMed ID: 5426816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.